🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Stage I Breast Cancer

Breast Cancer Survivorship Biorepository NCT05786664n/a1 site📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Electronic Health Record Review, Quality-of-Life Assessment, Survey Administration CtDNA Based MRD Testing for NAC Monitoring in TNBC NCT06230185n/a14 sites📍 Tucson📍 Aurora📍 Washington D.C. Personalis Inc. A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors NCT06609187Phase 11 site📍 Beijing Sichuan Baili Pharmaceutical Co., Ltd. · Tests: GNC-077 Validation of the Oncoliq Test for the Early Detection of Breast Cancer. NCT07331506n/a1 site📍 Buenos Aires Oncoliq US Inc · Tests: Peripheral blood draw MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles NCT03053193n/a134 sites📍 Birmingham📍 Anchorage📍 Phoenix Agendia · Tests: MammaPrint, BluePrint, and Full-Genome Testing A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers. NCT07593820Phase 12 sites📍 Barcelona📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: p95HER2.CAR-TECH2Me Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors NCT07360314Phase 19 sites📍 New Haven📍 Huntersville📍 Galveston EMD Serono Research & Development Institute, Inc. · Tests: M7437, M7437 Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases NCT07469267NA15 sites📍 Guiyang📍 Shijiazhuang📍 Harbin Fudan University · Tests: Entire regional nodal irradiation, Level I-II axillary irradiation Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction NCT06153836Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Neurotization Procedure, Questionnaire Administration, Subcutaneous Mastectomy A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer NCT06678269Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Abemaciclib, Radiation Therapy PARTial BREast RECONstruction With Chest Wall Perforator Flap NCT06728527n/a1 site📍 Cambridge Cambridge University Hospitals NHS Foundation Trust Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer NCT05874297NA1 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Best Practice, Internet-Based Intervention, Questionnaire Administration Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial NCT07474090NA4 sites📍 Winston-Salem📍 Winston-Salem📍 Richmond Wake Forest University Health Sciences · Tests: Exercise Intervention, Educational Intervention, Supportive Care, Biospecimen Collection, Magnetic Resonance Imaging Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC NCT07797218Phase 31 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: Docetaxel, Pyrotinib, Trastuzumab (Herceptin), Pertuzumab First in Human Study of TUB-030 in Patients With Advanced Solid Tumors NCT06657222Phase 1, Phase 220 sites📍 New Haven📍 Miami📍 Boston Gilead Sciences · Tests: TUB-030 A Study of the TheraBionic P1 Device in Breast Cancer NCT07218432NA8 sites📍 Clarkston📍 Detroit📍 Farmington Hills Barbara Ann Karmanos Cancer Institute · Tests: TheraBionic P1 Device Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer NCT05417308EARLY Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Minoxidil, Minoxidil, Quality-of-Life Assessment, Questionnaire Administration Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors NCT07288359Phase 1, Phase 216 sites📍 Atlanta📍 Nashville📍 San Antonio Novartis Pharmaceuticals · Tests: GVV858, Fulvestrant, Letrozole Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer NCT06121570Phase 11 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Sentinel Lymph Node Biopsy (SLNB), Doxorubicin, Epirubicin, Cyclophosphamide, Cyclophosphamide EORTC Metastatic Breast Cancer Module Development NCT07806266n/a22 sites📍 Ghent📍 Montreal📍 Toronto University of Leeds Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers NCT06800612n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Oncologic drugs administered for treatment of breast cancer, Oncologic drug administered for treatment of gynecologic c… A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors NCT05740956Phase 11 site📍 Beijing Jiangsu Hansoh Pharmaceutical Co., Ltd. · Tests: HS-10502 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) NCT04852887Phase 3832 sites📍 Birmingham📍 Mobile📍 Kingman NRG Oncology · Tests: Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane), Endocrine Therapy (Tamoxifen, Anastrozo… A Study of GC203 TIL in Advanced Malignant Solid Tumors NCT06375187Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Engineering Tumor Infiltrating Lymphocytes Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors NCT06840821Phase 1, Phase 21 site📍 Jinan Mainline Biosciences (Shanghai) Co., Ltd · Tests: MB0151 for injection Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer NCT06954831Phase 27 sites📍 Arcadia📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Cone-Beam Computed Tomography, Hypofractionated External Beam Radiation Therapy, Questionnaire Administration, Radiatio… TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients NCT05535192NA4 sites📍 Boston📍 Cleveland📍 Pittsburgh Dana-Farber Cancer Institute · Tests: THRIVE, Health Education Support Program A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer NCT04521764Phase 11 site📍 Rochester Mayo Clinic · Tests: Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein, Computed Tomography, Magnetic Reson…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy